Veradigm | MDRX - Loan Capital


Veradigm reported $200.4M in Loan Capital for its fiscal quarter ending in December of 2022.





Loan Capital Change Date
Alcidion AUD 318K 376K Dec/2025
Ambu A/S DKK 17M 3M Mar/2026
Amplifon EUR 610.34M 376.82M Mar/2026
Cardinal Health USD 8.25B 102M Mar/2026
Centene USD 16.31B 1.04B Mar/2026
Charles River Laboratories USD 2.66B 526.77M Mar/2026
Cigna USD 29.37B 1.5B Mar/2026
Coloplast 21.39B 1.34B Dec/2025
Computer Programs Systems USD 161.24M 122K Dec/2025
Convatec Group USD 1.18B 211.4M Dec/2024
CVS Health USD 60.53B 29M Mar/2026
Diasorin EUR 472.05M 199.95M Jun/2025
Elevance Health USD 30.77B 29M Mar/2026
General Electric Aerospace USD 18.17B 634M Mar/2026
Gulf Medical Proj AED 3.1M 151K Dec/2025
Humana USD 12.27B 95M Mar/2026
IQVIA Holdings USD 13.99B 105M Mar/2026
Laboratory Of America USD 5.9B 748.3M Mar/2026
Maximus USD 1.47B 37.39M Mar/2026
McKesson USD 5.26B 166M Mar/2026
Med Life RON 1.71B 260.03M Dec/2025
Molina Healthcare USD 3.77B 183M Mar/2026
Omnicell USD 167.9M 303K Mar/2026
Oriola-kd EUR 37.6M 700K Mar/2026
Owens Minor USD 1.8B 35.38M Dec/2025
Quest Diagnostics USD 5.16B 12M Mar/2026
Rede D'or Sao Luiz BRL 47.03B 460.24M Mar/2026
Siemens Healthineers EUR 11.42B 1.57B Mar/2026
Sonova Holding CHF 1.39B 209.8M Jun/2025
Supermax Corporation Bhd MYR 16.59M 439K Mar/2026
UnitedHealth USD 71.44B 880M Mar/2026
Veradigm USD 200.4M 69K Dec/2022
Xerox USD 3.48B 785M Jun/2025